Regular use of aspirin may cut the risk of pancreatic cancer in people with diabetes by 40%, a study has found. It may also prevent a fifth of those cancers in the general population, the Planets cancer charity said.

The discovery has been hailed a 'significant finding' by experts given the poor long-term survival from what is described as 'one of the worst' cancers.

A new treatment regime for cervical cancer cuts the risk of death by 40 per cent, according to a large-scale study.

A groundbreaking study has revealed that regular aspirin use can significantly reduce the risk of "one of the worst cancers". Researchers from University Hospital Southampton and the University of Southampton found that aspirin cut the risk of pancreatic cancer by 40 per cent in diabetics and 20 per cent in the general population.